Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses

At present, only surgical sterilization is available for veterinarians and pet owners seeking suppression of fertility in male dogs, in most countries. An alternative contraceptive alternative approach is GnRH releasing implants that desensitize the pituitary to the stimulatory effects of GnRH and t...

Full description

Bibliographic Details
Main Authors: Marc Antoine Driancourt, Joyce R. Briggs
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fvets.2020.00483/full
id doaj-0b6e3f49b2794b78ad2475b93dda79bf
record_format Article
spelling doaj-0b6e3f49b2794b78ad2475b93dda79bf2020-11-25T03:03:54ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692020-08-01710.3389/fvets.2020.00483543687Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and UsesMarc Antoine Driancourt0Joyce R. Briggs1Astek Consulting, Chateauneuf, FranceAlliance for Contraception in Cats and Dogs, Portland, OR, United StatesAt present, only surgical sterilization is available for veterinarians and pet owners seeking suppression of fertility in male dogs, in most countries. An alternative contraceptive alternative approach is GnRH releasing implants that desensitize the pituitary to the stimulatory effects of GnRH and thereby block testicular function (testosterone and sperm production). Two GnRH agonists (deslorelin and azagly-nafarelin) have been researched in controlled release formulations for this purpose. A deslorelin-releasing biodegradable implant, marketed under the name Suprelorin®, has been available in Australia and New Zealand since 2007, the European Union (EU) since 2008, and received regulatory approval in China and Mexico in late 2019. Two versions of the implant are available, one labeled for a minimum of 6 months of fertility suppression in male dogs, and the other for a minimum of 12 months in male dogs. Another GnRH agonist (azagly-nafarelin) was also included in a solid implant (Gonazon®). Research results showed it delivered 6-months to 1 year of suppressed fertility; however, it is not commercialized. This review paper summarizes research on the mechanism of action for these technologies and compiles and interprets the research on efficacy and safety. New findings on usage of the deslorelin releasing implant in countries where veterinarians and pet owners have this option is shared. Research on off-label use of the product in male dogs is also reviewed. This review aims to aid in the evaluation of the deslorelin releasing implant as an adjunct or alternative for surgical sterilization of male dogs.https://www.frontiersin.org/article/10.3389/fvets.2020.00483/fullmale dogsterilizecastrateneutercontraceptfertility control
collection DOAJ
language English
format Article
sources DOAJ
author Marc Antoine Driancourt
Joyce R. Briggs
spellingShingle Marc Antoine Driancourt
Joyce R. Briggs
Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses
Frontiers in Veterinary Science
male dog
sterilize
castrate
neuter
contracept
fertility control
author_facet Marc Antoine Driancourt
Joyce R. Briggs
author_sort Marc Antoine Driancourt
title Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses
title_short Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses
title_full Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses
title_fullStr Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses
title_full_unstemmed Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses
title_sort gonadotropin-releasing hormone (gnrh) agonist implants for male dog fertility suppression: a review of mode of action, efficacy, safety, and uses
publisher Frontiers Media S.A.
series Frontiers in Veterinary Science
issn 2297-1769
publishDate 2020-08-01
description At present, only surgical sterilization is available for veterinarians and pet owners seeking suppression of fertility in male dogs, in most countries. An alternative contraceptive alternative approach is GnRH releasing implants that desensitize the pituitary to the stimulatory effects of GnRH and thereby block testicular function (testosterone and sperm production). Two GnRH agonists (deslorelin and azagly-nafarelin) have been researched in controlled release formulations for this purpose. A deslorelin-releasing biodegradable implant, marketed under the name Suprelorin®, has been available in Australia and New Zealand since 2007, the European Union (EU) since 2008, and received regulatory approval in China and Mexico in late 2019. Two versions of the implant are available, one labeled for a minimum of 6 months of fertility suppression in male dogs, and the other for a minimum of 12 months in male dogs. Another GnRH agonist (azagly-nafarelin) was also included in a solid implant (Gonazon®). Research results showed it delivered 6-months to 1 year of suppressed fertility; however, it is not commercialized. This review paper summarizes research on the mechanism of action for these technologies and compiles and interprets the research on efficacy and safety. New findings on usage of the deslorelin releasing implant in countries where veterinarians and pet owners have this option is shared. Research on off-label use of the product in male dogs is also reviewed. This review aims to aid in the evaluation of the deslorelin releasing implant as an adjunct or alternative for surgical sterilization of male dogs.
topic male dog
sterilize
castrate
neuter
contracept
fertility control
url https://www.frontiersin.org/article/10.3389/fvets.2020.00483/full
work_keys_str_mv AT marcantoinedriancourt gonadotropinreleasinghormonegnrhagonistimplantsformaledogfertilitysuppressionareviewofmodeofactionefficacysafetyanduses
AT joycerbriggs gonadotropinreleasinghormonegnrhagonistimplantsformaledogfertilitysuppressionareviewofmodeofactionefficacysafetyanduses
_version_ 1724683927968284672